Page 9 - Manag Care Spec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ferring Pharmaceuticals: Ferring Presents New Analyses of Efficacy, Safety and Microbiome Composition Data at DDW 2022 for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic

New subgroup analyses presented at Digestive Disease Week (DDW) 2022 on the integrated efficacy results of Phase 2b and Phase 3 clinical studies of RBX2660. Data adds to the growing body

United statesKaplan meierKostenloser wertpapierhandelLisa ellenPaul feuerstadtCenters for diseaseUs centers for diseaseAmerican society for gastrointestinal endoscopyBrand communicationsSociety for surgery of the alimentary tractFerring pharmaceuticalsDrug administrationYale university school of medicineAmerican gastroenterological associationDigestive disease weekClostridioides difficile infection

Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C Difficile Infection at DDW 2022

Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at DDW 2022.

United statesSan diegoSahil khannaGlenn tillotsonLisa ellenPaul feuerstadtKen blountCenters for diseaseUs centers for diseaseAmerican society for gastrointestinal endoscopyBrand communicationsSociety for surgery of the alimentary tractFerring pharmaceuticalsDrug administrationFerring companyYale university school of medicine

Frontiers in Microbiology Publishes Article Detailing Novel Microbiome-based Biomarker of Post-Antibiotic Disruptions in Gut Microbiota

Frontiers in Microbiology Publishes Article Detailing Novel Microbiome-based Biomarker of Post-Antibiotic Disruptions in Gut Microbiota.

United statesLisa ellenKen blountMicrobiome health indexCenters for diseaseUs centers for diseaseBrand communicationsMicrobiome researchFerring pharmaceuticalsDrug administrationFerring microbiome health indexFerring companyRebiotix incFrontiersin microbiologyChief scientific officerVice president microbiome research

Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 2021

Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 2021
q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.

United statesPaul feuerstadtCenters for diseaseFerring pharmaceuticalsDrug administrationAmerican college of gastroenterologyFerring companyYale university school of medicineRebiotix incAmerican collegePresidential poster awardEnforcement discretionYale university schoolImproves outcomesReal world populationRetrospective study

Adherence to Medications for Noncommunicable Diseases - JMDH

Adherence to Medications for Noncommunicable Diseases - JMDH
dovepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dovepress.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomJawa timurSouth africaAz arbayjane sharqiJawa baratHimachal pradeshEnrique saenzGedik tekinemreJ clin pharmacolKayhan tetikCardiovasc disordJon edwardsAdella halimMultidiscip healthc